Global Pharmacovigilance and Risk Management Strategies Conference

Send Email 1.888.257.6457

Volver a Agenda

Session 6: Application and Use of Machine Learning, Artificial Intelligence, Automation, and Technology in Pharmacovigilance

Session Chair(s)

Susan Kindig, JD, MD

Prior Executive Director, Medical and Drug Safety

United States

This session will discuss use cases for Analytical/traditional AI and Generative AI and analyze the opportunities for expanding its’ impact/use. We will look at the impact of digital health on pharmacovigilance and forces at play with it’s ongoing impact. Lastly, we will explore ChatGPT for Safety professionals.

Learning Objective :
Develop an understanding of the practical uses of Analytical and Generative AI in pharmacoviglinace
Acquire targeted knowledge to evaluate and apply ChatGPT's capabilities within the context of safety operations
Leave with a clear framework for assessing the impact of Digital Health on Pharmacovigilance, including its benefits and challenges

Speaker(s)

Digital Health: A BooM or Burden to Pharmacovigilance?

Sibel D. Guerler, MSc

Bristol-Myers Squibb Company, Switzerland

Head, Innovation, Partnerships & Process Optimization, WorldWide Patient Safety

Use cases for Analytical/traditional AI and Generative AI: Where are the opportunities?

Tracey Boone, MBA

AbbVie, United States

Director

¿Tiene una cuenta?